Discussion on CardioExchange: A New Era in ICD Therapy — Get with the Programming!

Arthur Moss answers CardioExchange's questions about his research group's MADIT-RIT trial, which found a significant survival benefit from programming implantable cardioverter-defibrillators to minimize inappropriate therapy. Ask your own questions or share your perspective here.

CardioExchange is an online community hosted by the New England Journal of Medicine and Journal Watch and dedicated to improving cardiac patient care. Membership is free for medical professionals.